looks like a 9% increase from last qtr (Oct-Dec). Not really that much. Given the current rate of revenue increase, maybe the full year rev might touch 1.8-2 mill. What does that do to the share price?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
